Location:
Paul & Mildred Berg Hall, Li Ka Shing Center, Stanford
and virtual option
Welcome to 2024 Stanford Drug Discovery Symposium. This symposium provides a valuable and important platform for inspiring interdisciplinary exchange at the forefront of drug research and will support a fantastic networking experience. It provides a great resource for researchers, pharmaceutical companies, investment groups, and those in the wider biomedical community interested in discovering new drugs and improving patient care. We look forward to an exciting two days of talks and discussion.
— Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute
Lifetime Achievement Awardees
Helen Hobbs, MD
Philip O'Bryan Montgomery Jr., MD, Distinguished Chair in Developmental Biology
Eugene McDermott Distinguished Chair for the Study of Human Growth and Development
UT Southwestern Medical Center
Catherine Boileau, PhD, PharmD
Chair of Genetics Department
Bichat University Hospital
Participants
George Addona, PhD
Senior VP and Head of Discovery, Preclinical Development, and Translational Medicine, Merck
Rob Califf, MD
Commissioner of Food and Drugs, FDA
Paulo Fontoura, MD, PhD
Global Head and SVP of Neuroscience, Immunology, Ophthalmology, and Rare Diseases, Roche
Richard Klausner, MD
Chief Scientist and Founder, Altos Labs
Karen Nelson, PhD
Chief Scientific Officer, Thermo Fisher Scientific
David Rhew, MD
Global Chief Medical Officer, VP Healthcare, Worldwide Commercial, Microsoft
Gregory Verdine, PhD
Erving Professor of Chemistry, Harvard
Sharon Barr, PhD
EVP, BioPharmaceuticals, R&D, AstraZeneca
Patrizia Cavazzoni, MD
Director of the Center for Drug Evaluation and Research (CDER), FDA
Julie Grant, MBA, MPhil
General Partner
Canaan
Thomas Lynch, MD
President and Director, Fred Hutch Cancer Center
Shyam Patel, PhD
Senior Director of Business Development and Alliance Management, CIRM
Joni Rutter, PhD
Director, National Center for Advancing Translational Sciences (NCATS), NIH
Anne Wojcicki
Co-Founder and CEO, 23andMe
Paul Burton, MD, PhD
Chief Medical Officer, Amgen
Don Cleveland, PhD
Department Chair and Professor, Cellular and Molecular Medicine, UCSD
Aida Habtezion, MD
CMO and Head of Worldwide Medical & Safety, Pfizer
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research (CBER), FDA
Robert Plenge, MD, PhD
Executive Vice President, Chief Research Officer, Head of Research Bristol Myers Squibb
Daniel Skovronsky, MD, PhD
President Lilly Research Labs, Chief Scientific and Medical Officer, Eli Lilly and Co.
Bei Zhang, PhD
Corporate Vice President, Novo Nordisk
Organizers
Amanda Chase, PhD
Associate Director of Strategic Research Development
Stanford Cardiovascular Institute
Kuldev Singh, MD
Professor of Ophthalmology
Stanford University School of Medicine
Sanjay Malhotra, PhD
Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
OHSU
Joseph Wu, MD, PhD
Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine
Mark Mercola, PhD
Professor of Medicine
Stanford University School of Medicine
Francesca Mae G. Tongco, MS-HCA
Project Coordinator
Stanford Cardiovascular Institute
For additional information, please contact Joseph C. Wu, MD, PhD, or Francesca Tongco.